Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.32 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MAT2A | P31153 | 1/20 | 0.31 |
| ▸ | ICMT | O60725 | 1/20 | 0.30 |
| ▸ | NT5E | P21589 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27441002 | 0.96 | ABCG2 (0.33) | ABCG2NR3C1PGRLMNAPOLB | |
| SCHEMBL27440423 | 0.94 | ABCG2 (0.34) | ABCG2NR3C1PGRLMNAPOLB | |
| SCHEMBL27441096 | 0.94 | NT5E (0.31) | NR3C1PGRLMNAPOLBMAT2A | |
| SCHEMBL27440623 | 0.93 | ABCG2 (0.36) | ABCG2NR3C1PGRMAT2AICMT | |
| SCHEMBL27441089 | 0.92 | ENPP1 (0.32) | ABCG2NR3C1PGRLMNAPOLB | |
| SCHEMBL27440421 | 0.92 | ABCG2 (0.35) | ABCG2LMNAPOLBMAT2AICMT | |
| SCHEMBL24125568 | 0.92 | L3MBTL1 (0.32) | ABCG2NR3C1LMNA | |
| SCHEMBL25945105 | 0.91 | PTGER4 (0.35) | ABCG2LMNAPOLBMAT2A | |
| SCHEMBL27440536 | 0.91 | ABCG2 (0.34) | ABCG2LMNAPOLBMAT2ANT5E | |
| SCHEMBL25945098 | 0.90 | PTGER4 (0.35) | ABCG2LMNAPOLBMAT2AICMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12035623-B2 | Organic molecules for optoelectronic devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12035623-B2 | Organic molecules for optoelectronic devices | OR10J3, OR51E2, OCIAD2 | ABCG2 2819/4885NR3C1 4407/4885PGR 2974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.